GLP-1RA Therapy Linked to Major Survival and Cardiovascular Benefits in Psoriasis Patients

Psoriasis is increasingly recognized as a systemic disease, associated not only with cutaneous inflammation but also with elevated risks of myocardial infarction, stroke, depression, anxiety, and substance use disorders.